These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1813206)
1. The identification of high risk and practical strategies for a population based randomized trial of ovarian cancer screening. Scott IV Dis Markers; 1991; 9(3-4):133-52. PubMed ID: 1813206 [No Abstract] [Full Text] [Related]
2. Screening for early ovarian cancer. Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556 [TBL] [Abstract][Full Text] [Related]
10. [Ovarian cysts. The respective role of clinical examination, echography, biological markers and cytology]. Forest AM; Brémond A; Lévèque J; Viallet A J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):829-36. PubMed ID: 2277165 [TBL] [Abstract][Full Text] [Related]
11. [Clinical relevance of tumor markers for follow-up and therapy planning in ovarian cancer]. Böhm W; Lücke R; Ertle B; Benz R; Deinert S Arch Gynecol Obstet; 1989; 245(1-4):640-2. PubMed ID: 2802749 [No Abstract] [Full Text] [Related]
12. Screening for early ovarian cancer. Taylor KJ; Schwartz PE Radiology; 1994 Jul; 192(1):1-10. PubMed ID: 8208918 [TBL] [Abstract][Full Text] [Related]
13. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines]. Kausitz J Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762 [No Abstract] [Full Text] [Related]
14. Ovarian cancer screening: new trial tries new twists. McNeil C J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479 [No Abstract] [Full Text] [Related]
15. [Value of Ca 125 in preoperative diagnosis of adnexa tumors]. Krämer S; Jäger W; Schönwälder A; Wildt L; Lang N Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():48-9. PubMed ID: 8118355 [No Abstract] [Full Text] [Related]
16. [Tumor marker--personal experience. Mass survey and outpatients screening of pancreatic cancer]. Homma T Gan To Kagaku Ryoho; 1991 Mar; 18(3):497-501. PubMed ID: 2003745 [TBL] [Abstract][Full Text] [Related]
17. Screening for ovarian cancer. Powell MA J Am Acad Nurse Pract; 1992; 4(1):36-7. PubMed ID: 1605991 [No Abstract] [Full Text] [Related]
18. Ovarian cancer. van Nagell JR Gynecol Oncol; 1991 Nov; 43(2):89-91. PubMed ID: 1743563 [No Abstract] [Full Text] [Related]
19. Never say 100 percent. van Dalen A; Helfferich M; Keuning J Int J Biol Markers; 1988; 3(4):275. PubMed ID: 3235855 [No Abstract] [Full Text] [Related]
20. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone. Bast R; Woolas R BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445 [No Abstract] [Full Text] [Related] [Next] [New Search]